[HTML][HTML] Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from …
Background Nivolumab plus ipilimumab demonstrated promising clinical activity and
durable responses in sorafenib-treated patients with advanced hepatocellular carcinoma …
durable responses in sorafenib-treated patients with advanced hepatocellular carcinoma …